By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CSL Behring 

1020 First Avenue
P.O. Box 61501
King of Prussia  Pennsylvania  19406-0901  U.S.A.
Phone: 610-878-4000 Fax: 610-878-4009



Company News
CSL Behring To Create 200 New Jobs In $450 Million Expansion Of Illinois, Australia Sites 10/8/2014 9:00:43 AM
CSL Behring Expands Manufacturing Facility In Kankakee, Illinois To Meet Patients' Growing Needs 9/30/2014 9:22:43 AM
CSL Behring Announces Last Patient Treated In Phase 3 Study Of Fibrinogen Concentrate To Control Bleeding During Aortic Aneurysm Surgery 9/16/2014 8:28:08 AM
CSL Behring Release: Study Suggests C1-INH May Aid In Prevention Of Antibody-Mediated Rejection Following Kidney Transplant 7/30/2014 9:45:37 AM
CSL Behring Announces The 2014 Interlaken Leadership Awards Recipient 6/24/2014 8:26:41 AM
CSL Behring Launches Hizentra® Co-Pay Relief Program 5/20/2014 8:39:49 AM
CSL Behring Opens World-Class, Advanced Manufacturing Facility For Late-Stage Production Of Hemophilia Therapies Now In Development 5/9/2014 8:19:16 AM
CSL Behring Enrolls First Patient In Global Pediatric Phase 3 Pivotal Study Of Recombinant Factor VIII Single Chain (Rviii-Singlechain) To Treat Severe Hemophilia A 5/2/2014 8:44:25 AM
CSL Behring Continues Commitment To Donate Bleeding Disorder Medications To World Federation of Hemophilia 4/17/2014 1:24:11 PM
CSL Behring Launches My Access™ Cost Share Program During Hemophilia Awareness Month 3/27/2014 9:19:59 AM